The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2017
Filed:
Feb. 04, 2016
Applicant:
Covidien Ag, Neuhausen am Rheinfall, CH;
Inventor:
Ronald J. Podhajsky, Boulder, CO (US);
Assignee:
COVIDIEN AG, NEUHAUSEN AM RHEINFALL, unknown;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/12 (2006.01); A61K 31/522 (2006.01); A61K 31/519 (2006.01); A61K 31/53 (2006.01); A61K 31/00 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/53 (2013.01); A61B 18/12 (2013.01); A61K 31/00 (2013.01); A61K 31/519 (2013.01); A61K 31/522 (2013.01); A61B 2018/0063 (2013.01); A61B 2018/00333 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00452 (2013.01); A61B 2018/00547 (2013.01); A61B 2018/00559 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00589 (2013.01); A61B 2018/00619 (2013.01);
Abstract
A mammal undergoing an energy-based therapy is treated by administering at least one vasoconstrictive agent to the mammal prior to or during the procedure. The at least one vasoconstrictive agent is added in amounts sufficient to reduce or prevent vasodilation. This treatment method increases or promotes the size of the coagulation zone created after energy-based therapy.